Patterns of Cutaneous and Noncutaneous Immune-Related Adverse Events Among Patients With Advanced Cancer

In cohort study of 358 patients with cutaneous immune-related adverse events (cirAEs) linked to immune checkpoint-inhibitor therapy, the first cirAE often preceded subsequent irAEs and associations were observed between several types of cirAEs and types of irAEs.

JAMA Dermatology